Literature DB >> 9604948

Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm.

A E Tuinenburg1, D J Van Veldhuisen, F Boomsma, M P Van Den Berg, P J De Kam, H J Crijns.   

Abstract

Plasma atrial natriuretic peptide and endothelin are further elevated in patients with congestive heart failure and atrial fibrillation, compared to those with sinus rhythm. The higher plasma endothelin suggests that vasoconstriction is an important mechanism for hemodynamic compensation in these patients.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9604948     DOI： 10.1016/s0002-9149(98)00092-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  25 in total

1.  Big endothelin-1 as a predictor of atrial fibrillation recurrence after primary ablation only in patients with paroxysmal atrial fibrillation.

Authors:  H Wang; J Liu; P Fang; S Lei; X Li; Y Hou; S Zhang
Journal:  Herz       Date:  2012-06-06       Impact factor: 1.443

Review 2.  Mechanisms underlying the development of atrial arrhythmias in heart failure.

Authors:  Vias Markides; Nicholas S Peters
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

Review 3.  Diagnostic and therapeutic potential of the endothelin system in patients with chronic heart failure.

Authors:  H Krum; R Denver; A Tzanidis; P Martin
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

Review 4.  Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?

Authors:  L E Spieker; G Noll; F T Ruschitzka; T F Lüscher
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

Review 5.  [Atrial fibrillation].

Authors:  M G Hennersdorf; B E Strauer
Journal:  Internist (Berl)       Date:  2006-10       Impact factor: 0.743

6.  Endothelin system and atrial fibrillation post-cardiac surgery.

Authors:  Theofilos M Kolettis; Zenon S Kyriakides; Eleni Zygalaki; Stamatis Kyrzopoulos; Loukas Kaklamanis; Nikolaos Nikolaou; Evi S Lianidou; Dimitrios Th Kremastinos
Journal:  J Interv Card Electrophysiol       Date:  2008-02-09       Impact factor: 1.900

Review 7.  CRT-D therapy in patients with left ventricular dysfunction and atrial fibrillation.

Authors:  Frank Pelosi; Fred Morady
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-10       Impact factor: 1.468

Review 8.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

9.  N-terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohort.

Authors:  F W Asselbergs; M P van den Berg; S J Bakker; J E Signorovitch; H L Hillege; W H van Gilst; D J van Veldhuisen
Journal:  Neth Heart J       Date:  2008       Impact factor: 2.380

10.  A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study.

Authors:  Mustafa I Ahmed; Michel White; O James Ekundayo; Thomas E Love; Inmaculada Aban; Bo Liu; Wilbert S Aronow; Ali Ahmed
Journal:  Eur Heart J       Date:  2009-06-16       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.